Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III
Colorectal Cancer
About this trial
This is an interventional diagnostic trial for Colorectal Cancer focused on measuring colorectal cancer stage II and III
Eligibility Criteria
Inclusion Criteria: Signed and dated written informed consent Confirmed stage II or III (TNM) Patient with curative surgery for colorectal adenocarcinoma Total digestive endoscopy prior or post surgery. Age > 18 years old Normal liver ultrasound and chest X-ray or thoraco-abdomino pelvic computed tomography (CT) scan. In fertile women, efficient contraception or postmenopausal patient (amenorrhea for at least 1 year) Exclusion Criteria: Serious concomitant pathology Uncontrolled diabetes with a classical treatment (glycaemia >1.4 g/l) Other malignant tumour within the last 5 years (except for curatively treated basocellular carcinoma of the skin or in situ cervical carcinoma). Uncontrolled infection Women who are pregnant or lactating Inability to understand informed consent Psychological or geographic impossibility to follow up for three years.
Sites / Locations
- Cancérologie et Hépato-Gastro-Entérologie
- Institut François Baclesse
- Médecine Nucléaire
- Oncologie Médicale
- Oncologie Digestive